Medical and healthcare applications are possibly the fastest growing branch of nanotechnology. Nearly o­n a daily basis new groundbreaking results from basic research are reported. Many nanomedical concepts have entered into the phase of clinical studies, and the first nanotechnology-based medical products have been approved by the regulatory authorities.

Experts from all over the world will gather for the 6th NanoMed conference in Berlin to discuss the state of the art in biomedical applications of nanotechnology. The NanoMed conference series started in 1999 and has developed into o­ne of the European lead events in this field.

The scope of the conference covers the entire range of nanomedicine, including, among others,

• drug delivery, targeting and controlled release
• new concepts for cancer therapy
• innovative dental materials
• nanobioanalytics and diagnostic techniques
  
• nanomaterials for implants and regenerative medicine
• microbicidal coatings for sterility, general hygiene and drug packaging
• novel contrast agents
• miniaturization of biochips, and
• bio-labelling with quantum dots
• potential risks of nanomaterials
  

The NanoMed 2009 will put a special focus o­n nanomedical products that have already entered the market or are expected to do so in the near future. Therefore, strong emphasis will be put o­n issues like intellectual property, financing of nanotechnology enterprises, regulatory affairs, clinical studies, technology transfer, and strategic collaboration between academic research, R&D companies and the pharmaceutical industry.